CX Institutional’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$258K Sell
2,925
-1,136
-28% -$97.2K 0.01% 678
2026
Q2
$313K Buy
4,061
+1,551
+62% +$113K 0.01% 610
2026
Q1
$164K Sell
2,510
-91
-3% -$6.76K 0.01% 768
2025
Q4
$206K Buy
2,601
+219
+9% +$16.8K 0.01% 703
2025
Q3
$174K Buy
2,382
+6
+0.3% +$440 0.01% 732
2025
Q2
$180K Buy
2,376
+249
+12% +$17.6K 0.01% 661
2025
Q1
$162K Buy
+2,127
New +$158K 0.01% 655

Other funds holding SOLV

CX Institutional's SOLV Position: Q3 2026 in Review

CX Institutional reduced its Solventum (SOLV) stake by 28% in Q3 2026, selling an estimated $97.2K and leaving 2,925 shares worth $258K. The position accounts for 0.01% of the portfolio, ranked #678.

CX Institutional first reported a position in SOLV in Q1 2025 and has held it in 7 quarters since. The position peaked at $313K in Q2 2026. 175 funds tracked by Wall St. Rank hold SOLV as of Q3 2026.

  • CX Institutional held 2,925 shares of Solventum worth $258K as of Q3 2026.
  • CX Institutional sold 1,136 Solventum shares in Q3 2026, an estimated $97.2K.
  • Solventum made up 0.01% of CX Institutional's portfolio in Q3 2026, its #678 holding.
  • CX Institutional first reported a position in Solventum in Q1 2025 and has held it in 7 quarters since.
  • CX Institutional's Solventum position peaked at $313K in Q2 2026.
  • 175 funds tracked by Wall St. Rank held Solventum as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.